Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder

Am J Psychiatry. 1989 Jan;146(1):92-5. doi: 10.1176/ajp.146.1.92.

Abstract

Patients with panic disorder (N = 11) and age- and sex-matched normal control subjects (N = 11) were challenged with human growth hormone-releasing factor (GH-RF) (1 microgram/kg i.v.) or placebo in random order. The control subjects had significantly increased plasma growth hormone (GH) levels after GH-RF infusion whereas panic disorder patients did not. At 15 and 30 minutes after GH-RF infusion, GH concentrations were significantly higher in the control subjects than in the patients. These findings with GH-RF extend findings from earlier reports that patients with panic disorder show blunted GH response to phobic stimulation and clonidine.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Agoraphobia / blood*
  • Agoraphobia / diagnosis
  • Clinical Trials as Topic
  • Double-Blind Method
  • Fear / physiology*
  • Female
  • Growth Hormone / blood*
  • Growth Hormone-Releasing Hormone*
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Panic / physiology*
  • Phobic Disorders / blood*
  • Random Allocation

Substances

  • Growth Hormone
  • Growth Hormone-Releasing Hormone